ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 78 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $478 | -28.4% | 71,639 | +6.4% | 0.00% | -100.0% |
Q1 2023 | $668 | -99.5% | 67,325 | +115.4% | 0.00% | – |
Q2 2022 | $124,000 | -79.7% | 31,249 | -77.3% | 0.00% | -100.0% |
Q1 2022 | $612,000 | +63.6% | 137,741 | +46.9% | 0.00% | – |
Q4 2021 | $374,000 | +59.1% | 93,739 | +350.5% | 0.00% | – |
Q3 2021 | $235,000 | -0.8% | 20,810 | -0.5% | 0.00% | – |
Q2 2021 | $237,000 | +47.2% | 20,925 | +54.2% | 0.00% | – |
Q1 2021 | $161,000 | +41.2% | 13,566 | -19.0% | 0.00% | – |
Q4 2020 | $114,000 | +1800.0% | 16,747 | +1674.0% | 0.00% | – |
Q3 2020 | $6,000 | +50.0% | 944 | -18.1% | 0.00% | – |
Q2 2020 | $4,000 | -63.6% | 1,153 | -74.5% | 0.00% | – |
Q1 2020 | $11,000 | +266.7% | 4,519 | +677.8% | 0.00% | – |
Q3 2019 | $3,000 | +200.0% | 581 | +270.1% | 0.00% | – |
Q4 2018 | $1,000 | -99.9% | 157 | -99.7% | 0.00% | -100.0% |
Q3 2018 | $810,000 | +3421.7% | 58,745 | +1872.6% | 0.00% | – |
Q2 2018 | $23,000 | +2200.0% | 2,978 | +1389.0% | 0.00% | – |
Q1 2018 | $1,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |